title: Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model.
abstract: Although supplementation of preterm formula with polyunsaturated fatty acids (PUFA) has been shown to reduce the incidence of necrotizing enterocolitis (NEC) in animal models and clinical trials, the mechanisms remain elusive. We hypothesized that the protective effect of PUFA on NEC may be due to the ability of PUFA to suppress Toll-like receptor (TLR) 4 and platelet-activating factor receptor (PAFR) gene expression (molecules that are important in the pathogenesis of NEC) in epithelial cells. To investigate the efficacy of different PUFA preparations on NEC in a neonatal rat model, we compared the incidence of NEC among the four PUFA supplemented groups--A: arachidonic acid and docosahexaenoic acid (AA+DHA), B: egg phospholipids (EP), C: DHA, and D: control without PUFA. PUFA supplementation reduced the incidence of NEC and inhibited intestinal PAFR and TLR4 gene expression compared with the controls. To validate the in vivo observations, IEC-6 cells were exposed to PAF after pretreatment with AA or DHA. Both AA and DHA supplementation blocked PAF-induced TLR4 and PAFR mRNA expression in these enterocytes. These results suggest that PUFA modulates gene expression of key factors involved in experimental NEC pathogenesis. These effects might in part explain the protective effect of PUFA on neonatal NEC.
authors.affiliation: Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA.
authors.forename: Jing
authors.initials: J
authors.lastname: Lu
authors.forename: Tamas
authors.initials: T
authors.lastname: Jilling
authors.forename: Dan
authors.initials: D
authors.lastname: Li
authors.forename: Michael S
authors.initials: MS
authors.lastname: Caplan
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D019587:Dietary Supplements; D004195:Disease Models, Animal; D020345:Enterocolitis, Necrotizing / Q000235:genetics / Q000378:metabolism* / Q000517:prevention & control*; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage* / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects; D015994:Incidence; D007249:Inflammation / Q000235:genetics; D018836:Inflammation Mediators / Q000378:metabolism*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D005231:Fatty Acids, Unsaturated; D018836:Inflammation Mediators